» Articles » PMID: 31254745

Experimental Validation of Biocompatible Nanostructured Lipid Carriers of Sophorolipid: Optimization, Characterization and In-vitro Evaluation

Overview
Publisher Elsevier
Specialty Chemistry
Date 2019 Jun 30
PMID 31254745
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

To date, the potential of sophorolipids (an important class of glycolipids) has been exploited solely as amphipathic molecules but their ability to formulate lipid nanoparticles has never been explored. In this report, for the first time, lipid nanostructures coated with polysorbates (Tweens) were formulated by a hot dispersion method. By varying the amount of lipid, type of surfactant, and alcohol, dilution ratio etc., the formulation was optimized with respect to its stability, which is a central aspect of their potential applications. Their comprehensive physicochemical characterization was done using static and dynamic light scattering (SLS, DLS), small angle neutron scattering (SANS), zeta-potential, transmission electron microscopy (TEM), scanning electron microscopy (SEM), and atomic force microscopy (AFM) techniques. Further hemolysis study was conducted to understand the in-vitro cytotoxicity levels of the lipidic nanoparticles prior to its application as a potent drug delivery device for countermanding the problems associated with challenging tuberculosis and leprosy drug-Rifampicin. Attaining high entrapment efficiency and sustained release from the developed carrier, further interaction with bovine serum albumin was investigated, to understand the in-vivo behavior of the nanostructured lipid carriers (NLCs).

Citing Articles

Current Advances in Lipid-Based Drug Delivery Systems as Nanocarriers for the Management of Female Genital Tuberculosis.

Chavan D, Bhosale R, Thorat V, Yadav A, Patil S, Janugade B Cureus. 2024; 16(11):e74452.

PMID: 39726465 PMC: 11669736. DOI: 10.7759/cureus.74452.


"Enhancing Oral Drug Absorption: Overcoming Physiological and Pharmaceutical Barriers for Improved Bioavailability".

Maurya R, Vikal A, Patel P, Narang R, Kurmi B AAPS PharmSciTech. 2024; 25(7):228.

PMID: 39354282 DOI: 10.1208/s12249-024-02940-5.


Nanostructured lipid carriers loaded with morellic acid for enhanced anticancer efficacy: preparation, characterization, pharmacokinetics and anticancer evaluation.

Jia B, Li S, Li L, Wang T, Chen W, Chen G Am J Cancer Res. 2024; 14(3):1101-1120.

PMID: 38590403 PMC: 10998744. DOI: 10.62347/VBOX7111.


Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments.

Suman S, Chandrasekaran N, George Priya Doss C Clin Microbiol Rev. 2023; 36(4):e0008823.

PMID: 38032192 PMC: 10732062. DOI: 10.1128/cmr.00088-23.


Sophorolipid Candidates Demonstrate Cytotoxic Efficacy against 2D and 3D Breast Cancer Models.

Roberge C, Miceli R, Murphy L, Kingsley D, Gross R, Corr D J Nat Prod. 2023; 86(5):1159-1170.

PMID: 37104545 PMC: 10760934. DOI: 10.1021/acs.jnatprod.2c00804.